Potential candidate for substitution previous consultations

Some consultations on potential candidates for substitution have already taken place and have now been closed. The non-confidential information received in the previous consultations is published in the table below, starting with the most recent consultations. Please note that the information that has been declared confidential is not published but reserved for use only by the Biocidal Products Committee (BPC) members, the ECHA Secretariat and the European Commission.

There are currently no ongoing consultations.
 
Dinotefuran 18 - 165252-70-0 28/01/2014 Details
Glutaral,Glutaraldehyde,1,5-pentanedial 02, 03, 04, 06, 11, 12 203-856-5 111-30-8 15/02/2014 Details
Clothianidin 18 433-460-1 210880-92-5 11/04/2014 Details
Cybutryne 21 248-872-3 28159-98-0 11/04/2014 Details
Cyfluthrin 18 269-855-7 68359-37-5 11/04/2014 Details
Didecylmethylpoly(oxyethyl)ammonium propionate 8 - 94667-33-1 11/04/2014 Details
Hexaflumuron (ISO),1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea 18 401-400-1 86479-06-3 11/04/2014 Details
N,N'-methylenebismorpholine (MBM) 6 and 13 227-062-3 5625-90-1 11/04/2014 Details
5-Chloro-2-(4-chlorophenoxy)-phenol (DCPP) 1, 2, 4 429-290-0 3380-30-1 10/06/2014 Details
Medetomidine 21 - 86347-14-0 15/08/2014


Details
Triclosan 1 222-182-2 3380-34-5 15/08/2014 Details
Carbendazim 7, 9, 10 234-232-0 10605-21-7 02/09/2014 Details
Formaldehyde 2, 3 200-001-8 50-00-0 10/04/2015 Details
Polyhexamethylene biguanide with a mean number-average molecular weight (Mn) of 1600 and a mean polydispersity (D) of 1.8 (PHMB with Mn = 1600 and D = 1.8) 01, 02, 03, 04, 06, 09, 11 - 27083-27-8 10/04/2015 Details
Brodifacoum 14 259-980-5 56073-10-0 15/02/2016 Details
Bromadiolone 14 249-205-9 28772-56-7 15/02/2016 Details
Chlorophacinone 14 223-003-0 3691-35-8 15/02/2016 Details
Coumatetralyl 14 227-424-0 5836-29-3 15/02/2016 Details
Difenacoum 14 259-978-4 56073-07-5 15/02/2016 Details
Difethialone 14 - 104653-34-1 15/02/2016 Details
Flocoumafen 14 421-960-0 90035-08-8 15/02/2016 Details
Warfarin 14 201-377-6 81-81-2 15/02/2016 Details
Cyanamide 3, 18 206-992-3 420-04-2 21/04/2016 Details
Polyhexamethylene biguanide with a mean number-average molecular weight (Mn) of 1600 and a mean polydispersity (D) of 1.8 (PHMB with Mn = 1600 and D = 1.8) 5 -
27083-27-8
32289-58-0
21/04/2016 Details
3,3’-methylene-bis[5-methyloxazolidine] (Oxazolidin/MBO) [In the RAC Opinion on the CLH proposal for MBO the following name was used: Reaction product of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2)] 2, 6, 11, 12 and 13 266-235-8 66204-44-2 03/01/2017 Details
α,α′,α″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol (HPT) [In the RAC Opinion on the CLH proposal for HPT the following name was used: Reaction product of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1)] 2, 6, 11 and 13 246-764-0 25254-50-6 03/01/2017 Details
Acetamiprid 18 -
135410-20-7
160430-64-8
17/01/2017 Details
Azoxystrobin 7, 9, 10 - 131860-33-8 10/04/2017 Details
Chlorophene 2, 3 204-385-8 120-32-1 10/04/2017 Details
d-Allethrin 18 - 231937-89-6 10/04/2017 Details
esbiothrin/ d-trans-allethrin 75/25 18 - 260359-57-7 10/04/2017 Details
PHMB (1415; 4.7) i.e. Polyhexamethylene biguanide with a mean number-average molecular weight (Mn) of 1415 and a mean polydispersity (PDI) of 4.7 1, 2, 4, 5, 6 -
32289-58-0
1802181-67-4
10/04/2017 Details
(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl) cyclopropanecarboxylate (Cyphenothrin) 18 254-484-5 39515-40-7 20/06/2017 Details
Chlorfenapyr 18 - 122453-73-0 20/06/2017 Details
Cholecalciferol (Vitamin D3) 14 200-673-2 67-97-0 15/09/2017 Details
2,2-dibromo-2-cyanoacetamide (DBNPA) 4 233-539-7 10222-01-2 18/01/2019 Details
Cyanamide 3 and 18 206-992-3 420-04-2 25/08/2019 Details
Creosote 8 232-287-5 8001-58-9 22/12/2019 Details
Alpha-bromadiolone
≥ 76.9% 3-[(1R,3R)-(1S,3S)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin and ≤ 23.1% 3-[(1R, 3S)-(1S,3R)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin
PT 14 - - 14/04/2020 Details
Ethylene oxide PT 2 200-849-9 75-21-8 08/06/2020 Details
Boric acid 8 233-139-2 10043-35-3 27/10/2020 Details
Disodium tetraborate pentahydrate 8 215-540-4 12179-04-3 27/10/2020 Details
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) PT 8 262-104-4 60207-90-1 06/09/2021


Details
Hexaflumuron (ISO),1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea PT18 401-400-1 86479-06-3 15/10/2021

Details
2,2-dibromo-2-cyanoacetamide (DBNPA) PT 6 233-539-7 10222-01-2 25/03/2023

Details
formaldehyde released from the reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1) PT 2, 6, 11 and 13 - - 26/05/2023

Details
formaldehyde released from the reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2) PT 2, 6, 11, 12 and 13 - - 26/05/2023

Details
Cholecalciferol PT 14 200-673-2 67-97-0 07/11/2023

Details
Dinotefuran PT 18 605-399-0 165252-70-0 04/01/2024

Details
Medetomidine
(RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole (Racemic)
PT 21 - 86347-14-0 04/01/2024

Details